Concepedia

Jean Quancard

JQ

Statistics

Publications

22

Citations

1.4K

H-Index

16

Active since

2003

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Sorbonne Université

Centre National de la Recherche Scientifique

University of Tübingen

Jean Quancard is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2003–2021

22

Publications

22

Palladium-Catalyzed Enantioselective C-3 Allylation of 3-Substituted-1<i>H</i>-Indoles Using Trialkylboranes

Barry M. Trost, Jean Quancard · Journal of the American Chemical Society · 2006 · 532 citations

, , +9

Targeted inhibition of the COP9 signalosome for treatment of cancer

Anita Schlierf, Eva Altmann, Jean Quancard et al. · Nature Communications · 2016 · 204 citations · Full text

, , +17

A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis

Jean Quancard, Birgit Bollbuck, Philipp Janser et al. · Chemistry & Biology · 2012 · 128 citations

, , +10

An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient

Jean Quancard, Théo Klein, Shan‐Yu Fung et al. · Nature Chemical Biology · 2019 · 67 citations

, , +8

Development of Potent Inhibitors of Botulinum Neurotoxin Type B

Christine Anne, Serge Turcaud, Jean Quancard et al. · Journal of Medicinal Chemistry · 2003 · 61 citations

, , +13

1–5 of 22